Search: “dementia”

Dr. Virginia Kimonis and fellow UCI researchers are dedicated to finding genetic clues, giving new hope to families

Frank LaFerla, renowned for his Alzheimer’s work, hopes to raise the school’s profile

Michael Yassa, assistant professor of neurobiology & behavior, and his team of scientists found that caffeine has a positive effect on long-term memory in humans.  Their research, published Jan. 12 in the journal Nature Neuroscience, shows that caffeine enhances certain memories for up to 24 hours after it is consumed.

Irvine, Calif., Oct. 31, 2013 — As growing numbers of America’s baby boomers reach retirement, neuroscientists are expanding their efforts to understand and treat one of the leading health issues affecting this population: age-related neurological deterioration, including stroke and dementia. One factor coming under increased study is cerebral microbleeds, experienced by nearly 20 percent of people […]

UC Irvine’s trailblazing 90+ Study, launched in 2003 to learn more about the “oldest old,” the fastest-growing age group in the U.S., will continue for at least another five years, thanks to a $9.5 million renewal grant from the National Institute on Aging.

A study led by UC Irvine researchers has revealed some of the underlying neural factors that explain why people with Down syndrome are more susceptible to Alzheimer’s disease, diabetes and autistic spectrum disorders.

UC Irvine’s Center of Excellence on Elder Abuse & Neglect has developed an app to help law enforcement and first responders in California understand laws about elder abuse and neglect.

UC Irvine’s Program in Geriatrics will use federal grant for pilot program to preventing the abuse of people with dementia, called Take AIM Against Elder Abuse.

Efforts to treat disorders like Lou Gehrig’s disease, Paget’s disease, inclusion body myopathy and dementia will receive a considerable boost from a new research model created by UC Irvine scientists.

UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.